Today, we honor the 55th anniversary of the Stonewall Riots, a key milestone in the realization of LGBTQ+ rights. Despite progress in the U.S. and around the world, 92 countries still ban Pride events and criminalize LGBTQ+ life. With new HIV infections rising in many regions, access to HIV care remains a critical driver to get us closer to HIV elimination and the improvement of LGBTQ+ health. Our most recent article by Senior Consultant Kevin Lass and Associate Lily Stauble, MPH focuses on policies that strengthen access to HIV care in the U.S. and around the world, and why now is a critical moment for advocacy. Have a read here: https://lnkd.in/gqhRrWCc #Pride2024 #HIVAwareness #LGBTQRights #EndHIV #HealthForAll
Rabin Martin
Business Consulting and Services
New York, New York 9,966 followers
Together, we can make a lasting impact on global health – and your business.
About us
We’re Rabin Martin, a team of global health impact consultants. Driving better outcomes, access and equity – from strategy to execution. We design, develop and deliver effective solutions to unlock new markets and opportunities – creating creative ways for more people to access our client's medicines and vaccines, and generating support among key stakeholders. In today’s competitive and complex healthcare environment, leveraging Global Health expertise and partnerships, from strategy to execution, is a must-have in unlocking incremental growth. To do this, we bring together unrivaled global health and equity expertise – with decades of experience in commercial strategy, health system strengthening, health equity, and therapeutic area expertise – from cancer and chronic disease to rare diseases and maternal and child health. And we’re trained to see connections and know how to leverage local market knowledge, policy and partnerships to have a bigger impact on business and public health outcomes. It's why we've worked with the leading players in health, from entities within the UN, to pharma leaders like J&J and Takeda, to the Rockefeller and Bill & Melinda Gates Foundations. And have managed more than $2 billion in health and equity programming – across 80 markets including US, Europe and Low-to-Middle Income Countries. But a global health strategy that sits on a shelf doesn’t make an impact – on your business or the people who can’t access your medicines today. So, we follow it through to make a lasting impact. And we make it real by working side-by-side with you – managing everything from strategy and solution development to implementation, measurement, and evaluation. Do more for society. Deliver more for business. Questions? info@rabinmartin.com
- Website
-
http://www.rabinmartin.com
External link for Rabin Martin
- Industry
- Business Consulting and Services
- Company size
- 11-50 employees
- Headquarters
- New York, New York
- Type
- Public Company
- Specialties
- Strategy consulting, program design and implementation, partnership management, policy and advocacy, corporate responsibility, reputation management, Executive platforms, Commercial strategy, Signature ESG inititives, Financing models, Digital health, Health equity, Social determinants of health, Patient engagement, and Monitoring, measurement and evalution
Locations
-
Primary
Get directions
1285 Avenue of the Americas
Fifth Floor
New York, New York 10019, US
Employees at Rabin Martin
Updates
-
Happy #PrideMonth! 🏳️🌈 This month and beyond, Rabin Martin is taking the time to honor the voices, resilience, and activism of LGBTQ+ individuals worldwide. Here's to continued support, allyship, and celebration of our LGBTQ+ family, friends, and peers.
-
-
Energetic and pragmatic discussion at Wednesday’s Rabin Martin-hosted roundtable at the 77th World Health Assembly. Reimagining Partnerships: Pushing the envelope on solutions to advance access and equity encouraged conversation about what needs to change – within companies and externally – to ensure partnerships achieve sustainable, equitable impact at scale in LMICs. Thanks to Dr Cary Adams for expert moderation and key contributions from AstraZeneca, Gilead Sciences, GSK, Johnson & Johnson, MSD, Novartis, Novo Nordisk, Pfizer, Roche, and Takeda – as well as several other organizations, including Gavi, the Vaccine Alliance, City Cancer Challenge, H4D - Health for Development, and NCD Alliance. Stay tuned for our report out in the coming weeks!
-
-
Congratulations to AstraZeneca on the expansion of Healthy Heart Africa! It’s incredibly impressive that this initiative has screened more than 50 million people for hypertension and trained more than 11,000 healthcare workers over the past 10 years – and will now be taking on chronic kidney disease. As Dr. Aceng, Uganda’s Minister of Health stated when discussing the rise of non-communicable diseases in Africa: “Prevention, prevention, prevention is the way to go to make sure our populations stay alive and thrive.” We were pleased to attend this session during the World Health Assembly co-hosted by AZ and the Uganda Ministry of Health which featured panelists from the Renal Patients Society of Kenya, WHO, Amref Health Africa, PATH, and AZ and keynote addresses from the Ministers of Health of Egypt and Uganda. Learn more about the Healthy Heart Africa program: www.astrazeneca.com Photo caption: Tackling the rise of NCDs in Africa
-
-
Rabin Martin Partner, Terri Jackson will be speaking at the 2024 CMS Health Equity Conference on May 29th & 30th in Bethesda, Maryland! Join her and other health equity leaders, academics, and practitioners from around the country to explore topics in health equity and make an impact. Learn more and register today: https://lnkd.in/g6M-7pCa #HealthEquity #HealthEquityCon24
-
-
Yesterday, the BRIDGE Commission launched its recommendations report: Closing the Information Gap: Chronic Disease, Pregnancy, and Breastfeeding. BRIDGE’s multidisciplinary members are urging stakeholders to prioritize the inclusion of pregnant and breastfeeding women in research on chronic disease, highlighting that women deserve to have clear, evidence-based guidance on managing chronic conditions while they are pregnant or breastfeeding, to optimize their health and the health of their babies. Rabin Martin is proud to support BRIDGE in advancing the goal of a future where all women living with a chronic disease feel confident to make informed decisions about their care. We invite you to read the full report here: https://lnkd.in/ekgvNzcp Watch the webinar here: https://lnkd.in/eXwQ3xpu
-
-
🎙️ Rabin Martin CEO & Managing Partner, Rajni Samavedam, was on Fierce Pharma's podcast to discuss the transformative potential of digital health technologies in advancing health equity. 👂 Listen and learn about the importance of inclusivity and proactive outreach, the guiding principles for ensuring equal access, the critical role the private sector must play in promoting tech equity, and more: https://lnkd.in/eKYAAawf #HealthTechnology #HealthEquity #InnovationForAll
-
-
We are excited about tomorrow's launch of the BRIDGE Commission's Recommendations Report, Closing the Information Gap: Chronic Disease, Pregnancy, and Breastfeeding. STAT will be moderating a discussion with members of the commission on Tuesday, May 21st at 11: am EST. Register here: https://lnkd.in/eMCy6jw4 Rabin Martin has had the privilege of working with the esteemed BRIDGE commissioners for the past 18 months. We are proud to advance the goal of a future where all women living with chronic disease feel confident to make informed decisions about their care. Please join us tomorrow and learn more about BRIDGE's recommendations for the field. https://lnkd.in/gSzk43QY
-
-
One week from today, we will be attending the 77th World Health Assembly in Geneva, Switzerland. Our team, made up of CEO & Managing Partner Rajni Samavedam, Partner Maria Schneider, and Senior Consultants Serena Tohme, Nuria Balibrea, and Emma Dahill will be there to meet with partners and clients to discuss all things global health -- including inclusive digital innovation and partnerships to advance access and equity. Connect with us to explore opportunities for collaboration and to learn more about how Rabin Martin is making a lasting impact on global health. We hope to see you there!
-
-
Rabin Martin is proud to announce the publication of a new Framework to Guide Action in Accelerating Diagnosis and accompanying case studies – developed by the Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease. Co-chaired by Sanofi, Takeda and EURORDIS-Rare Diseases Europe, this multidisciplinary group of patient advocates, specialists, and researchers has set a bold vision: a clear path to a timely, accurate diagnosis for all children. It’s a privilege for Rabin Martin to support the commission’s vital work. Learn more here: https://lnkd.in/eRDKNHMx
-